Clinical Trial

Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population

Study acronym: HELPER
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this study is to define the role of H. pylori eradication in the prevention of gastric cancer and its precursors in the context of a population-based endoscopic screening program.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2014-04-09; most recent amendment 2024-12-25.
Status change: Recruiting → Active, Not Recruiting 2020-06-02
Trial Details
NCT Number NCT02112214
Lead Sponsor National Cancer Center, Korea
Collaborators: International Agency for Research on Cancer, Chonnam National University Hospital, Chung-Ang University Hospital, Pusan National University Hospital, Kyungpook National University Hospital, Uijeongbu St. Mary's Hospital/The Catholic University, Kangdong Sacred Heart Hospital, Incheon St.Mary's Hospital/The Catholic University, SMG-SNU Boramae Medical Center, Chuncheon Sacred Heart Hospital, Kosin University Gospel Hospital
Conditions Gastric Cancer, Helicobacter Pylori Infection
Enrollment 5,224 participants
Start Date 2014-06
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-27